Log in

NASDAQ:ICEL - Cellular Dynamics International Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume264,387 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cellular Dynamics International, Inc develops and produces functioning human cells in industrial quantities. The Company's products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell products). It markets its products for use in life science in vitro research and development, as well as applied product testing, stem cell banking and in vivo cellular therapeutics. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:ICEL
CUSIPN/A
Phone+1-608-3105100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ICEL News and Ratings via Email

Sign-up to receive the latest news and ratings for ICEL and its competitors with MarketBeat's FREE daily newsletter.


Cellular Dynamics International (NASDAQ:ICEL) Frequently Asked Questions

What is Cellular Dynamics International's stock symbol?

Cellular Dynamics International trades on the NASDAQ under the ticker symbol "ICEL."

How were Cellular Dynamics International's earnings last quarter?

Cellular Dynamics International Inc (NASDAQ:ICEL) issued its earnings results on Thursday, March, 5th. The company reported ($0.36) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.44) by $0.08. The firm earned $6.60 million during the quarter, compared to analysts' expectations of $5 million. View Cellular Dynamics International's Earnings History.

Has Cellular Dynamics International been receiving favorable news coverage?

Press coverage about ICEL stock has trended negative on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cellular Dynamics International earned a daily sentiment score of -2.4 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an impact on the company's share price in the near term. View News Stories for Cellular Dynamics International.

What other stocks do shareholders of Cellular Dynamics International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cellular Dynamics International investors own include SLS International (SLS), Endocyte (ECYT), Endo International (ENDP), EXACT Sciences (EXAS), Halozyme Therapeutics (HALO), Ionis Pharmaceuticals (IONS), Nektar Therapeutics (NKTR), Puma Biotechnology (PBYI), Zogenix (ZGNX) and Potash Co. of Saskatchewan (POT).

How do I buy shares of Cellular Dynamics International?

Shares of ICEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cellular Dynamics International's official website?

The official website for Cellular Dynamics International is http://www.cellulardynamics.com/.

How can I contact Cellular Dynamics International?

Cellular Dynamics International's mailing address is 525 Science Dr, MADISON, WI 53711-1082, United States. The company can be reached via phone at +1-608-3105100.


MarketBeat Community Rating for Cellular Dynamics International (NASDAQ ICEL)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  106 (Vote Outperform)
Underperform Votes:  90 (Vote Underperform)
Total Votes:  196
MarketBeat's community ratings are surveys of what our community members think about Cellular Dynamics International and other stocks. Vote "Outperform" if you believe ICEL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICEL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: Risk Tolerance

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel